Has Megan Kelsey received payments from drug or device companies?

Yes. Drug and device makers reported $1,024 in general payments to Megan Kelsey across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Megan Kelsey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Megan Kelsey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Megan Kelsey

Pediatric Endocrinology · Aurora, CONPI 1194871707

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Covidien LP accounts for 63.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $475 and has fallen 76.4% since, to $112 in 2025. That places this record below the midpoint for pediatric endocrinology clinicians in CO, where the typical reported total is $1,520.

$1,024in general payments, 2019–2025

Across 17 payments — averaging $60.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Covidien LP$650
Novo Nordisk$215
Chiesi USA, Inc.$112
Medtronic$46

$706,057in research payments, 2019–2025

Across 136 payments — averaging $5191.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Rhythm Pharmaceuticals, Inc.$650K
Daiichi Sankyo Inc.$20K
Janssen Research & Development, LLC$17K
Merck$12K
Boehringer Ingelheim Pharma GmbH & Co.kg$6K
Boehringer Ingelheim France S.a.s.$578
plus $27 from 1 others

What the payments were for

Food & beverage$1,024100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Covidien LP	12	$650
Novo Nordisk	2	$215
Chiesi USA, Inc.	1	$112
Medtronic	2	$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Signia$133
MYALEPT$112

How this compares

$1,024 in reported general payments places this provider in the 45th percentile of 34 pediatric endocrinology providers in Colorado.

See all pediatric endocrinology providers in Colorado →

Other pediatric endocrinology in Aurora

Kimberly SimmonsAurora$323K
Gregory ForlenzaAurora$200K
Marian RewersAurora$178K
Raj WadwaAurora$61K
Philip ZeitlerAurora$58K
Andrea SteckAurora$33K
Erin CobryAurora$15K
Georgeanna KlingensmithAurora$14K
Melanie CreeAurora$13K
Natalie NokoffAurora$13K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →